Novartis has revealed that the FDA has accepted its resubmission for cholesterol-lowering drug Leqvio – rejected unexpectedly by the US regulator last year – and has set a new action date of 1 ...
Even as Novartis takes home a partial win in court tied to its key blockbuster Entresto, the Swiss drugmaker continues to ...
Global drugmaker Novartis will lay off 427 employees in East Hanover this spring and summer, after it let go of 235 at the ...
Daily Voice on MSN2d
Pharma Giant Cutting 400+ More East Hanover Jobs Ahead Of Major Drug Patent's ExpirationPharmaceutical company Novartis is laying off more than 400 employees at its East Hanover facility as part of a restructuring ...
Novartis Pharmaceuticals is removing hundreds of New Jersey employees from its company. The global drugmaker will lay off 427 ...
Swiss pharma major Novartis (NOVN: VX) is set to lay off 427 employees at its East Hanover, New Jersey, site as part of a ...
The massive pharmacy benefit manager plans to stop requiring coverage authorizations for roughly 80 drugs used to treat ...
Novartis also says it has “multiple significant ... drug Entresto as well as continued growth of cholesterol medication Leqvio, the company is focused on evolving its cardiovascular portfolio.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback